Quantcast

Latest pharmaceutical industry Stories

2014-07-20 23:00:10

Membrane filtration is a widely used separation technique in the pharmaceutical and biotechnology industries and its adoption rate in Europe and North America is very high - http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html. (PRWEB) July 21, 2014 The “Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein...

2014-07-18 23:01:05

In May 2014, the FDA released a draft guidance that covers the selection and approval process for proposed names of both prescription and nonprescription human drugs and biologics. FDAnews has teamed with drug-naming expert Dr. Susan Proulx to present a 90-minute webinar that will look closely at the draft guidance and its recommended 4-step process. Falls Church, VA (PRWEB) July 18, 2014 Choosing the Right Drug Name: How to Increase Your Chances for Approval **FDAnews Webinar** July...

2014-07-18 20:21:37

CHAPEL HILL, N.C., July 18, 2014 /PRNewswire/ -- Patient engagement is a critical success factor in pharmaceutical marketing today. Although marketing is one of the principal groups that handle patient engagement activities, Government Affairs and Public Policy groups within the pharmaceutical industry are among the functions that are becoming increasingly involved in activities and initiatives to positively impact the "patient journey." Recent research by benchmarking firm, Best Practices,...

2014-07-18 16:23:22

TARRYTOWN, N.Y., July 18, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2014 financial and operating results on Tuesday, August 5, 2014, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call Information To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International). A link to the...

2014-07-18 16:21:29

MINNEAPOLIS, MN, July 18, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA), an industrial biotechnology company producing renewable chemicals, announced today that it will report its financial results for the second quarter 2014 on Thursday August 7, 2014. BioAmber will also hold a live investor conference call and webcast at 4:30 PM Eastern Time (1:30 PM PT) to discuss the results. Conference Call and Webcast Thursday, August 7, 2014 @ 4:30 PM Eastern Time / 1:30 PM Pacific Time...

2014-07-18 08:24:51

BELLEVILLE, ON, July 18, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today provided a key regulatory update on its flagship Phase 3 program, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) sterile suspension for the treatment of patients with Bacillus Calmette-Guérin (BCG) refractory high grade non-muscle invasive bladder cancer. MCNA U.S. Regulatory Update Following several months of active dialogue with the U.S. Food and Drug Administration (FDA),...

2014-07-18 08:24:41

BUENA, N.J., July 18, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced the Company will hold a conference call at 4:15 pm ET on Thursday, July 24, 2014 to discuss the 2nd quarter 2014 results. http://photos.prnewswire.com/prnvar/20130827/MM70487LOGO The Company invites you to listen to the call by dialing 1-877-870-4263. International participants should call 1-412-317-0790. Canadian...

2014-07-17 23:05:29

Required Change Reflects Reports of Additional Clotting Not Related to Condition Covered by Current Warnings DALLAS (PRWEB) July 17, 2014 The U.S. Food & Drug Administration (FDA) has ordered testosterone therapy drug makers to provide additional warnings in regard to blood clots to those already in place, the national law firm of Baron and Budd reports. This development occurs as federal litigation involving testosterone treatment lawsuits proceed in the U.S. District Court, Northern...

2014-07-17 12:30:57

New Manhattan Research Study from Decision Resources Group Helps Marketers Understand How Physicians Are Using Multichannel Information and Services from Pharma BURLINGTON, Mass., July 17, 2014 /PRNewswire/ -- Decision Resources Group's new Manhattan Research study, ePharma Physician(®) 2014, indicates that physicians are looking to pharmaceutical companies to help them keep patients engaged in their healthcare by providing patient services. The study shows strong physician interest in...

2014-07-17 12:30:54

BRISBANE, Calif., July 17, 2014 /PRNewswire/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that pirfenidone has been granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA). This designation is reserved for drugs that are intended to treat a serious or life threatening disease or condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related